In various studies, therapeutic options including oral administration of IL-12 [40], oral administration of a synthetic agonist of Toll-like receptor 9 [41], or blockade of platelet-activating factor and histamine [42] have been investigated for treatment of food allergy. This evidence concerns the gene TLR9 and food allergy.